FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|April 20, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 20, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 40.1% of total US population have received at least 1 dose
• 26% of total US population are fully vaccinated
• 26% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 33.6%
2. New Mexico: 32.7%
3. Vermont: 32.6%
4. Connecticut: 32.5%
5. Alaska: 32.4%
2. New Mexico: 32.7%
3. Vermont: 32.6%
4. Connecticut: 32.5%
5. Alaska: 32.4%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 31 779 242 confirmed cases
• 568 284 deaths
• 568 284 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 722 131
2. Texas: 2 856 095
3. Florida: 2 178 783
4. New York: 2 008 514
5. Illinois: 1 306 690
2. Texas: 2 856 095
3. Florida: 2 178 783
4. New York: 2 008 514
5. Illinois: 1 306 690
Deaths: California has the most deaths due to COVID-19 with 61 109 reported fatalities, followed by New York with 51 689, and Texas with 49 623.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 142 456 745 confirmed cases, 3 035 844 deaths, and 81 608 039 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
The FDA granted Breakthrough Device designation to Natera's cell-free DNA multi-cancer early detection assay. What it means for primary care.
Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
2
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
3
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
4
Building Clinician Confidence to Prescribe HIV PrEP in Primary Care
5